Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IRCT20220813055671N1Phase 2Completed
Phase 2 trial of granulocyte colony-stimulating factor and platelet-rich plasma in Recurrent Implantation Failure (RIF) and female infertility, sponsored by Isfahan University of Medical Sciences. Started Jan 2023; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on IRCT20220813055671N1.